Empery Asset Management’s Biofrontera BFRIW Stock Holding History

Empery Asset Management’s Portfolio BFRIW Stock Details BFRIW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$45K	Hold	75,000	–	–	0.27%	42
2022 Q2	$53K	Hold	75,000	–	–	0.29%	30
2022 Q1	$110K	Hold	75,000	–	–	0.52%	27
2021 Q4	$270K	Buy	+75,000	New	+$162K	0.56%	24

Other funds holding BFRIW

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Empery Asset Management's BFRIW Position: Q3 2022 in Review

Empery Asset Management held its Biofrontera (BFRIW) position steady in Q3 2022 at 75,000 shares worth $45K. The position accounts for 0.27% of the portfolio, ranked #42.

Empery Asset Management first reported a position in BFRIW in Q4 2021 and has held it in 4 quarters since. The position peaked at $270K in Q4 2021. 5 funds tracked by Wall St. Rank hold BFRIW as of Q3 2022.

Empery Asset Management held 75,000 shares of Biofrontera worth $45K as of Q3 2022.
Empery Asset Management left its Biofrontera share count unchanged in Q3 2022.
Biofrontera made up 0.27% of Empery Asset Management's portfolio in Q3 2022, its #42 holding.
Empery Asset Management first reported a position in Biofrontera in Q4 2021 and has held it in 4 quarters since.
Empery Asset Management's Biofrontera position peaked at $270K in Q4 2021.
5 funds tracked by Wall St. Rank held Biofrontera as of Q3 2022.

Based on Empery Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.